Tradestie Institutional Equity Comparison Engine

PRE vs PMI โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PMI Overall Edge

PMI Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Picard Medical, Inc. (PMI) driven by superior Valuation, Momentum & Technical, Options & Structure while PRE counters with relative strength in Growth & Margin. Fundamentally, PRE trades at N/M Forward P/E with -32.5% operating margin (+172.2% YoY revenue) versus PMI at N/M Forward P/E and -248.1% operating margin (+38.6% YoY). In options structure, PRE sits in BREAKDOWN (13th %ile IV; Dealer Gamma Walls on Pro) against PMI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner PMI
PRE N/M vs PMI N/M Fwd P/E
Growth & Margin Winner PRE
Op Margin -32.5% vs -248.1% ยท YoY +172.2% vs +38.6%
Momentum & Technical Winner PMI
1Y -16.3% vs +107.2% ยท 52W Pos 6% vs 34%
Options & Structure Winner PMI
BREAKDOWN (13th %ile IV) vs UNCLASSIFIED (N/A IV)
PRE NASDAQ
Prenetics Global Limited Class A Ordinary Share
Laboratory Analytical Instruments
$10.31
-0.39% 1D
Market Cap $205.5M
1M Return -38.37%
1Y Return -16.28%
Forward P/E N/M
Unified AI Score
40.8 / 100 SELL
Tech 25.0 Fund 45.0 Flow 55.0 Mom 44.0
PMI NYSE American
Picard Medical, Inc.
Surgical & Medical Instruments & Apparatus
$6.30
-2.17% 1D
Market Cap $17.1M
1M Return -34.58%
1Y Return +107.24%
Forward P/E N/M
Unified AI Score
48.4 / 100 HOLD
Tech 39.0 Fund 45.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: PRE -16.28% PMI +107.24% Spread: +164.31 pp (PMI Lead)

Pillar 3 Annualized Quarterly Run-Rate Revenue & Operating Margin Trajectory (USD-Normalized)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period PRE Revenue PMI Revenue PRE Op. Margin PMI Op. Margin Margin Edge
Q2 '25 $50M $10M -70.0% -165.2% PRE
Q3 '25 $90M $0M -27.8% -293.8% PRE
Q4 '25 $150M $0M -35.9% -297.6% PRE
Q1 '26 $140M $0M -27.0% -392.3% PRE

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: PRE (3) vs PMI (6)
Institutional Metric PRE PMI Criterion Row Winner
Market Capitalization Scale $205.5M $17.1M Larger Scale PRE
Trailing P/E Ratio Valuation N/M 2.9x Lower Multiple PMI
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +172.2% +38.6% Higher Growth PRE
Operating Margin (TTM) Profitability -32.5% -248.1% Higher Margin PRE
Net Profit Margin Profitability -32.6% 0.0% Higher Margin PMI
Return on Equity (ROE) Capital Efficiency -67.8% 0.0% Higher ROE PMI
52-Week Range Position Momentum 6% ($9โ€“$27) 34% ($0โ€“$18) Stronger Trend PMI
Beta / 30D Volatility Risk Regime 1.66ฮฒ ยท 141% Vol 54.06ฮฒ ยท 134% Vol Lower Realized Risk PMI
Unified Institutional Score Composite Signal 40.8 / 100 (SELL) 48.4 / 100 (HOLD) Higher Composite PMI

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full PRE vs PMI Buy Guide
PRE BREAKDOWN
59d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 13th %ile
IV Regime Compressed (<25th %ile)
Live PRE Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PMI UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live PMI Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither PRE nor PMI registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.